SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2022 financial results on Wednesday, August ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced the nationwide launch of a new suite of consumer-friendly, at-home diagnostic test kits.

Cue Health, a San Diego biotech that ascended during the pandemic through mega funding and partnerships for its rapid COVID-19 test, said Wednesday that it is laying off half of its workforce as it ...

NEW YORK (Reuters) -Tarsadia Investments wants Cue Health to review its strategy, including a possible sale, to help reverse its stock plunge of 98% in the last two years. The investment firm, which ...

Fresh off the announcement that it would be slimming down its operations, with 170 manufacturing workers laid off this summer, Cue Health is back to focusing on long-term growth. Amid somewhat ...

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24. The company, which grew to ...

Cue’s board of directors decided to file for bankruptcy after failing to improve operational efficiency and its capital structure. In March, the healthcare technology company’s CEO stepped down and co ...

Pfizer is once again looking to a diagnostic developer to drum up interest in its COVID-19 drug. Having kicked off the strategy last year through deals with Lucira Health and Roche, the Big Pharma has ...

Welcome to Cue Health's Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question and answer ...

NEW YORK, Aug 31 (Reuters) - Tarsadia Investments is urging Cue Health HLTH.O to review its strategy, including options for a possible sale, to help reverse its stock plunge of 98% in the last two ...